Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

"Two hits - one stone"; increased efficacy of cisplatin-based therapies by targeting PCNA's role in both DNA repair and cellular signaling.

Søgaard CK, Blindheim A, Røst LM, Petrović V, Nepal A, Bachke S, Liabakk NB, Gederaas OA, Viset T, Arum CJ, Bruheim P, Otterlei M.

Oncotarget. 2018 Aug 21;9(65):32448-32465. doi: 10.18632/oncotarget.25963. eCollection 2018 Aug 21.

2.

Anti-Cancer Potential of Homemade Fresh Garlic Extract Is Related to Increased Endoplasmic Reticulum Stress.

Petrovic V, Nepal A, Olaisen C, Bachke S, Hira J, Søgaard CK, Røst LM, Misund K, Andreassen T, Melø TM, Bartsova Z, Bruheim P, Otterlei M.

Nutrients. 2018 Apr 5;10(4). pii: E450. doi: 10.3390/nu10040450.

3.

APIM-peptide targeting PCNA improves the efficacy of docetaxel treatment in the TRAMP mouse model of prostate cancer.

Søgaard CK, Moestue SA, Rye MB, Kim J, Nepal A, Liabakk NB, Bachke S, Bathen TF, Otterlei M, Hill DK.

Oncotarget. 2018 Jan 27;9(14):11752-11766. doi: 10.18632/oncotarget.24357. eCollection 2018 Feb 20.

4.

Increased Anticancer Efficacy of Intravesical Mitomycin C Therapy when Combined with a PCNA Targeting Peptide.

Gederaas OA, Søgaard CD, Viset T, Bachke S, Bruheim P, Arum CJ, Otterlei M.

Transl Oncol. 2014 Dec;7(6):812-23. doi: 10.1016/j.tranon.2014.10.005.

5.

Targeting proliferating cell nuclear antigen and its protein interactions induces apoptosis in multiple myeloma cells.

Müller R, Misund K, Holien T, Bachke S, Gilljam KM, Våtsveen TK, Rø TB, Bellacchio E, Sundan A, Otterlei M.

PLoS One. 2013 Jul 31;8(7):e70430. doi: 10.1371/journal.pone.0070430. Print 2013.

6.

Mutation screening in a Norwegian cohort with pheochromocytoma.

Sjursen W, Halvorsen H, Hofsli E, Bachke S, Berge A, Engebretsen LF, Falkmer SE, Falkmer UG, Varhaug JE.

Fam Cancer. 2013 Sep;12(3):529-35. doi: 10.1007/s10689-013-9608-0.

PMID:
23407919

Supplemental Content

Loading ...
Support Center